Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular physical activity. Emerging evidence suggests that light to moderate physical activity may help reduce systemic and intestinal inflammation and improve IBD-related outcomes. However, access to structured physical activity programs remains limited, and personal or professional constraints may hinder participation. This pilot study aims to assess the feasibility and impact of a remotely delivered Adapted Physical Activity (APA) program on the quality of life of patients with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. This study evaluates the effects of a 12-weeks remote APA intervention on quality of life as the primary outcome. Secondary objectives include assessing changes in anxiety and depression, fatigue levels, IBD activity, and smoking behavior. The findings from this study may inform the development of scalable, non-pharmacological strategies to support symptom management and well-being in individuals with IBD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 years and older

• Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months

• Patient is motivated to participate in the Adapted Physical Activity (APA) program

• Medical certificate confirming fitness to engage in remote physical activity

• Access to a digital device with internet connectivity enabling use of the MOOV+ application at home

• Written informed consent freely given after appropriate information

• Affiliation with, or beneficiary of, a national health insurance system

Locations
Other Locations
France
GHI Le Raincy Montfermeil
RECRUITING
Montfermeil
CHU Nantes
NOT_YET_RECRUITING
Nantes
Contact Information
Primary
Stephane NAHON, Professor
stephane.nahon@ght-gpne.fr
+33141708000
Time Frame
Start Date: 2025-09-15
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 72
Treatments
Experimental: Pre- and post-intervention comparison following participation in the Adapted Physical Activity (APA)
There is no comparator group at this stage of the research. Patient data will be compared before and after participation in the Adapted Physical Activity (APA) program.
Sponsors
Leads: Raincy Montfermeil Hospital Group
Collaborators: Janssen Cilag S.A.S.

This content was sourced from clinicaltrials.gov